TAD packs



TAD 600 mg/4 ml
powder and solvent for injection.

TAD 2500 mg/25 ml
powder and solvent for infusion.

Pharmaceutical Forms:

  • Powder and solvent for injection.
  • Powder and solvent for infusion.

Therapeutic indications Prophylaxis of neuropathy following chemotherapy treatment with cisplatin or analogues.

Biomedica Foscama

The ideal partner for the development and manufacturing of sterile products

Do you want to be our partner?
Contact us